Wunderlich Bettina, Laskow Thomas, Li Huifen, Zhang Li, Abrams Engle, Tian Jing, Yu Jun, Chen Yiyin, Tavenier Juliette, Huang Yushu, Talaat Kawsar, Bream Jay H, Xue Qian-Li, Pawelec Graham, Leng Sean X
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Immun Ageing. 2023 Jul 31;20(1):38. doi: 10.1186/s12979-023-00362-8.
Seasonal influenza causes significant morbidity and mortality with a disproportionately high disease burden in older adults. Strain-specific hemagglutination-inhibition (HAI) antibody titer is a well-established measure of humoral immunity against influenza and pre-vaccination HAI titer is a valuable indicator of pre-existing humoral immunity at the beginning of each influenza season in highly vaccinated older adults. While vaccine-induced HAI antibody titers are known to wane over time, accurate assessment of their interseason waning has been challenging. This is because pre-vaccination HAI titers are routinely measured using current season vaccine strain antigens instead of the prior season vaccines with which individuals were immunized; as such, they do not accurately represent residual antibody titers from prior season vaccination. This study took advantage of available pre-vaccination HAI titers measured using both current and prior season vaccine strain antigens in a longitudinal influenza immunization study with participants enrolled for multiple consecutive influenza seasons from 2014 through 2017. Influenza A virus (IAV) H3N2 and influenza B virus (IBV) strains in the vaccine formula changed in 2015 and again in 2016 season. IAV H1N1 vaccine strain remained the same from 2014 through 2016 seasons, but changed in 2017. We also investigated factors contributing to pre-existing humoral immunity.
Interseason waning of HAI titers was evident, but rates of waning varied among vaccine strains and study seasons, from 18% (p = .43) to 61% (p < .01). Rates of waning were noticeably greater when pre-vaccination HAI titers were measured by the routine approach, i.e., using current season vaccine strain antigens, from 33% (p = .12) to 83% (p < .01), adjusting for age at prior study season, sex, race, and education. This was largely because the routinely measured pre-vaccination HAI titers underrepresented residual HAI titers from prior season vaccinations. Moreover, interseason antibody waning and prior season post-vaccination HAI titers had significant and independent associations with pre-vaccination HAI titers.
The routinely measured pre-vaccination HAI titer overestimates interseason HAI antibody waning as it underestimates residual antibody titers from prior season vaccination when virus strains in the vaccine formula change. Moreover, interseason antibody waning and prior season post-vaccination HAI titers independently contribute to pre-existing humoral immunity in this highly vaccinated, community-dwelling older adult population.
季节性流感会导致严重的发病和死亡,在老年人中疾病负担尤其高。毒株特异性血凝抑制(HAI)抗体滴度是一种公认的针对流感的体液免疫指标,对于接种率高的老年人而言,接种前HAI滴度是每个流感季节开始时既有体液免疫的重要指标。虽然已知疫苗诱导的HAI抗体滴度会随时间下降,但准确评估其季节间的下降情况具有挑战性。这是因为接种前HAI滴度通常使用当前季节疫苗毒株抗原进行测量,而非个体接种的上一季节疫苗;因此,它们不能准确代表上一季节接种后残留的抗体滴度。本研究利用了在一项纵向流感免疫研究中,使用当前和上一季节疫苗毒株抗原测量的接种前HAI滴度数据,该研究的参与者从2014年至2017年连续多个流感季节入组。2015年以及2016年流感季节,疫苗配方中的甲型流感病毒(IAV)H3N2和乙型流感病毒(IBV)毒株发生了变化。2014年至2016年流感季节,IAV H1N1疫苗毒株保持不变,但在2017年发生了变化。我们还研究了促成既有体液免疫的因素。
HAI滴度的季节间下降明显,但下降率因疫苗毒株和研究季节而异,从18%(p = 0.43)至61%(p < 0.01)。当接种前HAI滴度采用常规方法测量,即使用当前季节疫苗毒株抗原时,下降率明显更高,在对前一研究季节的年龄、性别、种族和教育程度进行调整后,从33%(p = 0.12)至83%(p < 0.01)。这主要是因为常规测量的接种前HAI滴度未能充分体现上一季节接种后残留的HAI滴度。此外,季节间抗体下降以及上一季节接种后HAI滴度与接种前HAI滴度存在显著且独立的关联。
当疫苗配方中的病毒毒株发生变化时,常规测量的接种前HAI滴度会高估季节间HAI抗体的下降情况,因为它低估了上一季节接种后残留的抗体滴度。此外,在这个接种率高的社区居住老年人群体中,季节间抗体下降以及上一季节接种后HAI滴度独立地促成了既有体液免疫。